Texas Capital Cuts United States Antimony Target to $8

Analyst Matthew Key lowered his price target on United States Antimony stock to $8 from $9.50 while maintaining a buy rating.

Updated on Nov. 20, 2026 in Public Companies

Isometric editorial illustration of unmarked metal ingots beside a smelter chimney and a pile of dark ore in muted oxblood, teal, and mustard tones.
Texas Capital analyst Matthew Key cut his United States Antimony price target to $8 from $9.50 on Thursday while keeping a buy rating. AI Illustration. Upload story photo >

Texas Capital analyst Matthew Key cut his price target on United States Antimony stock to $8 from $9.50, while keeping a buy rating. The shares fell 6.5% by 3:00 p.m. ET on the day of the revision.

Why it matters

The price target cut is the third reduction on the stock this week, following revisions from Alliance Global and B. Riley. Investors tracking the company are watching how analysts reconcile its valuation with its recent share price.

Matthew Key's $8 target implies 259% upside from the $2.23 prior close, while the stock trades at 9.1 times trailing sales against a five-year average of 5.9. Analysts have not disclosed the operational reasons behind the successive revisions.

The players

United States Antimony

United States Antimony is a publicly traded company that operates antimony smelting and precious metal refining facilities in Montana and Mexico.

Texas Capital

Texas Capital is a financial services firm whose research division issues equity analyst ratings and price targets on publicly traded companies.

The details

Key's revision followed Alliance Global's cut to $9 from $13.50 on Monday and B. Riley's cut to $6 from $10 on Wednesday. United States Antimony operates an antimony smelter and precious metal refinery in Montana, along with a smelter and three mills in Mexico.

Timeline

  1. Monday: Alliance Global cut its price target to $9 from $13.50.

  2. Wednesday: B. Riley cut its price target to $6 from $10.

  3. November 20, 2026: Texas Capital cut its price target to $8; shares fell 6.5% by 3:00 p.m. ET.

Market Landscape

Three analysts cut targets within a single week while two maintained buy ratings, a pattern that diverges from a uniform analyst view on the stock. The stock's premium trailing sales multiple compared with its five-year average frames the valuation debate.

Investors relying on analyst price targets should note that three firms have lowered theirs this week, and the revised figures sit far below the stock's prior levels. Anyone weighing a position should check the company's latest filings and sales trends before acting on the targets.

The takeaway

Analyst price targets reflect each firm's own valuation model, so a cluster of cuts signals shifting expectations rather than a single verdict. Readers should compare target revisions against company fundamentals.

Further reading

Track more analyst coverage in the Public Companies section.

Source note: This article includes information reported by The Motley Fool.